Now the hard part: getting it to work.
This could be a useful diagnostic tool for soldiers in combat zones.
According to the FDA, structural analysis and 44 deaths associated with the drug are evidence that it's an opioid.
“These findings indicate that FDA's animal program may need to be strengthened in some important areas.”
Known as Luxturna, it can be used to treat children and adults suffering from mutation-induced vision loss.
Companies using stem cells to grow replacement organs may face fewer administrative obstacles.
It monitors whether or not you've taken your medication.
The final decision now rests with the FDA itself.
This small sensor can replace fingersticks for 10 days at a time.
The decision comes a week after the FDA gave pharmaceutical company Novartis approval to use the treatment.
Over 350,000 people subscribe to our newsletter.
Sign in to join the conversation.